Bellevue Group Ag Charles River Laboratories International, Inc. Transaction History

Bellevue Group Ag

$6.38 Billion
Q1 2024

A detailed history of Bellevue Group Ag transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Bellevue Group Ag holds 229,697 shares of CRL stock, worth $46.3 Million. This represents 0.98% of its overall portfolio holdings.

Number of Shares

229,697

Previous 217,756 5.48%

Holding current value

$46.3 Million

Previous $51.5 Million 20.9%

% of portfolio

0.98%

Previous 0.8%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$203.52 - $273.43 $2.43 Million - $3.27 Million	11,941 Added 5.48%	229,697 $62.2 Million
Q4 2023 Feb 14, 2024	SELL	$164.52 - $238.84 $1.91 Million - $2.77 Million	-11,586 Reduced 5.05%	217,756 $51.5 Million
Q3 2023 Nov 14, 2023	SELL	$194.44 - $217.61 $16.6 Million - $18.5 Million	-85,171 Reduced 27.08%	229,342 $44.9 Million
Q2 2023 Aug 14, 2023	BUY	$183.71 - $210.25 $2.22 Million - $2.54 Million	12,067 Added 3.99%	314,513 $66.1 Million
Q1 2023 May 15, 2023	BUY	$191.89 - $259.92 $2.39 Million - $3.24 Million	12,469 Added 4.3%	302,446 $61 Million

Q4 2022 Feb 14, 2023	BUY	$197.11 - $250.07 $5.32 Million - $6.75 Million	26,984 Added 10.26%	289,977 $63.2 Million
Q3 2022 Nov 14, 2022	BUY	$182.44 - $250.54 $5.82 Million - $8 Million	31,924 Added 13.82%	262,993 $51.8 Million
Q2 2022 Aug 11, 2022	BUY	$204.13 - $302.4 $21.4 Million - $31.7 Million	104,663 Added 82.8%	231,069 $49.4 Million
Q1 2022 May 13, 2022	BUY	$255.51 - $362.11 $15.5 Million - $21.9 Million	60,495 Added 91.78%	126,406 $35.9 Million
Q4 2021 Feb 10, 2022	BUY	$351.38 - $448.68 $907,263 - $1.16 Million	2,582 Added 4.08%	65,911 $24.8 Million
Q3 2021 Nov 12, 2021	SELL	$372.64 - $458.3 $42.8 Million - $52.7 Million	-114,941 Reduced 64.48%	63,329 $26.1 Million
Q2 2021 Aug 12, 2021	SELL	$294.17 - $371.65 $2.98 Million - $3.76 Million	-10,115 Reduced 5.37%	178,270 $65.9 Million
Q1 2021 May 12, 2021	BUY	$249.67 - $299.48 $11.3 Million - $13.6 Million	45,367 Added 31.72%	188,385 $54.6 Million
Q4 2020 Feb 16, 2021	SELL	$222.0 - $252.62 $46.2 Million - $52.6 Million	-208,065 Reduced 59.26%	143,018 $35.7 Million
Q3 2020 Nov 16, 2020	SELL	$175.56 - $226.45 $2.59 Million - $3.34 Million	-14,750 Reduced 4.03%	351,083 $79.5 Million
Q2 2020 Aug 13, 2020	BUY	$118.84 - $189.72 $4.07 Million - $6.49 Million	34,210 Added 10.32%	365,833 $63.8 Million
Q1 2020 May 14, 2020	BUY	$98.9 - $178.34 $4.8 Million - $8.65 Million	48,525 Added 17.14%	331,623 $41.9 Million
Q4 2019 Feb 14, 2020	BUY	$126.05 - $152.76 $34.6 Million - $42 Million	274,798 Added 3310.82%	283,098 $43.2 Million
Q3 2019 Nov 14, 2019	BUY	$125.07 - $143.67 $1.04 Million - $1.19 Million	8,300 New	8,300 $1.1 Million

Others Institutions Holding CRL

# of Institutions

728

Shares Held

51.3M

Call Options Held

183K

Put Options Held

346K

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $10.2B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bellevue Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Bellevue Group Ag with notifications on news.

Account

Bellevue Group Ag Charles River Laboratories International, Inc. Transaction History